Denison Consulting and Newmeasures Join Forces to Advance the Future of Employee Listening and Organizational Performance

Denison Consulting and Newmeasures Join Forces to Advance the Future of Employee Listening and Organizational Performance

ANN ARBOR, Mich., Jan. 13, 2026 /PRNewswire/ -- Denison Consulting and Newmeasures announced that they have joined forces to advance the future of employee listening and organizational performance. Effective January 1, 2026, Denison Consulting and...

Peak Energy acquires 48 MW ready-to-build solar portfolio in Japan

Peak Energy acquires 48 MW ready-to-build solar portfolio in Japan

The portfolio of projects will come online progressively over 2026-2028 and be combined with battery storage to maximize climate impact and cost savings for customers. SINGAPORE and TOKYO, June 17, 2025 /PRNewswire/ -- Peak Energy, one of the...

Shell completes acquisition of combined-cycle power plant in priority U.S. trading market

Shell completes acquisition of combined-cycle power plant in priority U.S. trading market

HOUSTON, Jan. 24, 2025 /PRNewswire/ -- Shell Energy North America (US), L.P. (SENA), a subsidiary of Shell plc (Shell), has completed the previously announced 100% equity stake acquisition of RISEC Holdings, LLC (RISEC), which owns a 609-megawatt...

Published in Annals of Oncology: Disitamab Vedotin Combined with PD-1 Inhibitor is a Promising Treatment for Locally Advanced or Metastatic Urothelial Carcinoma

Published in Annals of Oncology: Disitamab Vedotin Combined with PD-1 Inhibitor is a Promising Treatment for Locally Advanced or Metastatic Urothelial Carcinoma

YANTAI, China, Jan. 8, 2025 /PRNewswire/ -- On Janurary 7th, 2025, Annals of Oncology (IF: 56.7), a top oncology journal globally, published remarkable long-term follow-up results of a phase 1b/2 clinical trial on Disitamab Vedotin (DV) (developed...

menu
menu